CD274 and head and neck squamous cell carcinoma: The results of this analysis are consistent with those of previous studies showing that TMB, PD‐L1, and TcellinfGEP are related to response to anti‐PD‐1 therapy in multiple cancers2 and with those of a recent analysis of the KEYNOTE‐012 trial in patients with HNSCC.13